ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extracorporeal Photopheresis (ECP) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-3W17417
Home | Market Reports | Health| Health Conditions
Global Extracorporeal Photopheresis ECP Market Research Report 2024
BUY CHAPTERS

Global Extracorporeal Photopheresis (ECP) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-3W17417
Report
October 2025
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Terumo
Macopharma
Mallinckrodt Pharmaceuticals
Med Tech Solutions

Extracorporeal Photopheresis (ECP) Market

The global Extracorporeal Photopheresis (ECP) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Bronchiolitis Obliterans Syndrome (BOS) accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Extracorporeal Photopheresis (ECP) leading manufacturers including Haemonetics, Fresenius Kabi, Terumo, Macopharma, Mallinckrodt Pharmaceuticals, Med Tech Solutions, etc., dominate supply; the top five capture approximately % of global revenue, with Haemonetics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Extracorporeal Photopheresis (ECP) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Extracorporeal Photopheresis (ECP) Market Report

Report Metric Details
Report Name Extracorporeal Photopheresis (ECP) Market
Segment by Type
  • Photopheresis Protocols
  • Photosensitizing Agents
  • Other
Segment by Application
  • Bronchiolitis Obliterans Syndrome (BOS)
  • Recurrent Acute Rejection
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Haemonetics, Fresenius Kabi, Terumo, Macopharma, Mallinckrodt Pharmaceuticals, Med Tech Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Extracorporeal Photopheresis (ECP) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Extracorporeal Photopheresis (ECP) Market report?

Ans: The main players in the Extracorporeal Photopheresis (ECP) Market are Haemonetics, Fresenius Kabi, Terumo, Macopharma, Mallinckrodt Pharmaceuticals, Med Tech Solutions

What are the Application segmentation covered in the Extracorporeal Photopheresis (ECP) Market report?

Ans: The Applications covered in the Extracorporeal Photopheresis (ECP) Market report are Bronchiolitis Obliterans Syndrome (BOS), Recurrent Acute Rejection, Other

What are the Type segmentation covered in the Extracorporeal Photopheresis (ECP) Market report?

Ans: The Types covered in the Extracorporeal Photopheresis (ECP) Market report are Photopheresis Protocols, Photosensitizing Agents, Other

1 Study Coverage
1.1 Introduction to Extracorporeal Photopheresis (ECP): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Extracorporeal Photopheresis (ECP) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Photopheresis Protocols
1.2.3 Photosensitizing Agents
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Extracorporeal Photopheresis (ECP) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bronchiolitis Obliterans Syndrome (BOS)
1.3.3 Recurrent Acute Rejection
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Extracorporeal Photopheresis (ECP) Revenue Estimates and Forecasts 2020-2031
2.2 Global Extracorporeal Photopheresis (ECP) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Extracorporeal Photopheresis (ECP) Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Extracorporeal Photopheresis (ECP) Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Photopheresis Protocols Market Size by Players
3.3.2 Photosensitizing Agents Market Size by Players
3.3.3 Other Market Size by Players
3.4 Global Extracorporeal Photopheresis (ECP) Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Extracorporeal Photopheresis (ECP) Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Extracorporeal Photopheresis (ECP) Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
6.4 North America Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Extracorporeal Photopheresis (ECP) Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
7.4 Europe Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Extracorporeal Photopheresis (ECP) Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
8.4 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
9.4 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
10.4 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Haemonetics
11.1.1 Haemonetics Corporation Information
11.1.2 Haemonetics Business Overview
11.1.3 Haemonetics Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.1.4 Haemonetics Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.1.5 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.1.6 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.1.7 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.1.8 Haemonetics Extracorporeal Photopheresis (ECP) SWOT Analysis
11.1.9 Haemonetics Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.2.4 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.2.5 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.2.6 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.2.7 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.2.8 Fresenius Kabi Extracorporeal Photopheresis (ECP) SWOT Analysis
11.2.9 Fresenius Kabi Recent Developments
11.3 Terumo
11.3.1 Terumo Corporation Information
11.3.2 Terumo Business Overview
11.3.3 Terumo Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.3.4 Terumo Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.3.5 Terumo Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.3.6 Terumo Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.3.7 Terumo Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.3.8 Terumo Extracorporeal Photopheresis (ECP) SWOT Analysis
11.3.9 Terumo Recent Developments
11.4 Macopharma
11.4.1 Macopharma Corporation Information
11.4.2 Macopharma Business Overview
11.4.3 Macopharma Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.4.4 Macopharma Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.4.5 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.4.6 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.4.7 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.4.8 Macopharma Extracorporeal Photopheresis (ECP) SWOT Analysis
11.4.9 Macopharma Recent Developments
11.5 Mallinckrodt Pharmaceuticals
11.5.1 Mallinckrodt Pharmaceuticals Corporation Information
11.5.2 Mallinckrodt Pharmaceuticals Business Overview
11.5.3 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.5.4 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.5.5 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.5.6 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.5.7 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.5.8 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) SWOT Analysis
11.5.9 Mallinckrodt Pharmaceuticals Recent Developments
11.6 Med Tech Solutions
11.6.1 Med Tech Solutions Corporation Information
11.6.2 Med Tech Solutions Business Overview
11.6.3 Med Tech Solutions Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.6.4 Med Tech Solutions Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.6.5 Med Tech Solutions Recent Developments
12 Extracorporeal Photopheresis (ECP)Industry Chain Analysis
12.1 Extracorporeal Photopheresis (ECP) Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Extracorporeal Photopheresis (ECP) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Extracorporeal Photopheresis (ECP) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Terumo
Macopharma
Mallinckrodt Pharmaceuticals
Med Tech Solutions
List of Tables
 Table 1. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Extracorporeal Photopheresis (ECP) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Extracorporeal Photopheresis (ECP) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Extracorporeal Photopheresis (ECP) Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Extracorporeal Photopheresis (ECP) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Photopheresis (ECP) as of 2024)
 Table 11. Global Extracorporeal Photopheresis (ECP) Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Extracorporeal Photopheresis (ECP) Companies Headquarters
 Table 13. Global Extracorporeal Photopheresis (ECP) Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Extracorporeal Photopheresis (ECP) Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Extracorporeal Photopheresis (ECP) Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Extracorporeal Photopheresis (ECP) Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Extracorporeal Photopheresis (ECP) Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Extracorporeal Photopheresis (ECP) High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
 Table 25. North America Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
 Table 27. Europe Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Extracorporeal Photopheresis (ECP) Investment Opportunities and Key Challenges
 Table 31. Central and South America Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Extracorporeal Photopheresis (ECP) Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Haemonetics Corporation Information
 Table 35. Haemonetics Description and Major Businesses
 Table 36. Haemonetics Product Features and Attributes
 Table 37. Haemonetics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Haemonetics Revenue Proportion by Product in 2024
 Table 39. Haemonetics Revenue Proportion by Application in 2024
 Table 40. Haemonetics Revenue Proportion by Geographic Area in 2024
 Table 41. Haemonetics Extracorporeal Photopheresis (ECP) SWOT Analysis
 Table 42. Haemonetics Recent Developments
 Table 43. Fresenius Kabi Corporation Information
 Table 44. Fresenius Kabi Description and Major Businesses
 Table 45. Fresenius Kabi Product Features and Attributes
 Table 46. Fresenius Kabi Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Fresenius Kabi Revenue Proportion by Product in 2024
 Table 48. Fresenius Kabi Revenue Proportion by Application in 2024
 Table 49. Fresenius Kabi Revenue Proportion by Geographic Area in 2024
 Table 50. Fresenius Kabi Extracorporeal Photopheresis (ECP) SWOT Analysis
 Table 51. Fresenius Kabi Recent Developments
 Table 52. Terumo Corporation Information
 Table 53. Terumo Description and Major Businesses
 Table 54. Terumo Product Features and Attributes
 Table 55. Terumo Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Terumo Revenue Proportion by Product in 2024
 Table 57. Terumo Revenue Proportion by Application in 2024
 Table 58. Terumo Revenue Proportion by Geographic Area in 2024
 Table 59. Terumo Extracorporeal Photopheresis (ECP) SWOT Analysis
 Table 60. Terumo Recent Developments
 Table 61. Macopharma Corporation Information
 Table 62. Macopharma Description and Major Businesses
 Table 63. Macopharma Product Features and Attributes
 Table 64. Macopharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Macopharma Revenue Proportion by Product in 2024
 Table 66. Macopharma Revenue Proportion by Application in 2024
 Table 67. Macopharma Revenue Proportion by Geographic Area in 2024
 Table 68. Macopharma Extracorporeal Photopheresis (ECP) SWOT Analysis
 Table 69. Macopharma Recent Developments
 Table 70. Mallinckrodt Pharmaceuticals Corporation Information
 Table 71. Mallinckrodt Pharmaceuticals Description and Major Businesses
 Table 72. Mallinckrodt Pharmaceuticals Product Features and Attributes
 Table 73. Mallinckrodt Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Mallinckrodt Pharmaceuticals Revenue Proportion by Product in 2024
 Table 75. Mallinckrodt Pharmaceuticals Revenue Proportion by Application in 2024
 Table 76. Mallinckrodt Pharmaceuticals Revenue Proportion by Geographic Area in 2024
 Table 77. Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) SWOT Analysis
 Table 78. Mallinckrodt Pharmaceuticals Recent Developments
 Table 79. Med Tech Solutions Corporation Information
 Table 80. Med Tech Solutions Description and Major Businesses
 Table 81. Med Tech Solutions Product Features and Attributes
 Table 82. Med Tech Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Med Tech Solutions Recent Developments
 Table 84. Raw Materials Key Suppliers
 Table 85. Distributors List
 Table 86. Market Trends and Market Evolution
 Table 87. Market Drivers and Opportunities
 Table 88. Market Challenges, Risks, and Restraints
 Table 89. Research Programs/Design for This Report
 Table 90. Key Data Information from Secondary Sources
 Table 91. Key Data Information from Primary Sources


List of Figures
 Figure 1. Extracorporeal Photopheresis (ECP) Product Picture
 Figure 2. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Photopheresis Protocols Product Picture
 Figure 4. Photosensitizing Agents Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Bronchiolitis Obliterans Syndrome (BOS)
 Figure 8. Recurrent Acute Rejection
 Figure 9. Other
 Figure 10. Extracorporeal Photopheresis (ECP) Report Years Considered
 Figure 11. Global Extracorporeal Photopheresis (ECP) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Extracorporeal Photopheresis (ECP) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Region (2020-2031)
 Figure 15. Global Extracorporeal Photopheresis (ECP) Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Photopheresis Protocols Revenue Market Share by Player in 2024
 Figure 18. Photosensitizing Agents Revenue Market Share by Player in 2024
 Figure 19. Other Revenue Market Share by Player in 2024
 Figure 20. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Type (2020-2031)
 Figure 21. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Application (2020-2031)
 Figure 22. North America Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
 Figure 24. North America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
 Figure 31. Europe Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 34. France Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 46. India Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
 Figure 54. Central and South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
 Figure 60. South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
 Figure 66. Extracorporeal Photopheresis (ECP) Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Photopheresis Market Research Report 2024
Global Extracorporeal Life Support System ECLS Market Research Report 2025
Extracorporeal Blood Purification Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Extracorporeal Life Support ECLS Devices Market Research Report 2024
Extracorporeal Blood Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasmapheresis Membrane and Device Market Research Report 2024
Extracorporeal Blood Purification Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Extracorporeal CO2 Removal Devices Market Research Report 2024
Global Extracellular Polymeric Substances Market Research Report 2025
Global Extracorporeal Life Support Technology Market Research Report 2024
Global Photoelectric Medical Devices Market Research Report 2024
Global Plasmapheresis Systems Market Research Report 2025
Global Extracorporeal Cardiopulmonary Support Assist System Market Research Report 2024
Global Medical Apheresis System Market Research Report 2024
Extracorporeal Membrane Oxygenation Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Apheresis Column Market Research Report 2025
Plasmapheresis Filters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global MCP and eMCP Market Research Report 2025
Global Low density Lipoprotein Apheresis Therapy Market Research Report 2024
Global Leukapheresis Products Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions